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Editorial on the Research Topic
Advances in Transoral Approaches for Laryngeal Cancer
If the reader googles words such as “transoral laser (or robotic) surgery for laryngeal cancer,” he will
quickly realize how such relatively new topics are among the most actively discussed in the recent
years by the international head and neck cancer community. Whether this is truly (and exclusively)
the result of the publication in 1993 of Steiner’s first large series of glottic tumors treated by transoral
laser microsurgery (TLM) (1) and the introduction of the European Laryngological Society (ELS)
classification scheme of endoscopic cordectomies in 2000 (2) as hypothesized by Mendelsohn and
Remacle, can be a matter of debate. History will tell: as in all human developments, longer follow-
up time and assessment by judges that are at some distance are needed to properly evaluate the
historical roots of such a complex scientific, economic, and social phenomenon. However, no one
can forget the value of such seminal papers and their groundbreaking effect when first published
in the last century. Once the revolutionary Steiner’s concept of multi-bloc trans-tumor resection
of large volume laryngo-hypopharyngeal malignancies was demonstrated to not hamper any of
the mainstays of oncologic radicality, given that an adequate preoperative three-dimensional (3D)
model of the tumor to be removed had been fully understood, a number of “traditional” surgeons
(or their younger scholars) gradually shifted their indications for management of laryngeal cancer
from open to transoral approaches.
In this sense, minimally invasive surgery of the larynx essentially relies on the perfect mastering
of every possible diagnostic tool available. As demonstrated by Ruytenberg et al. Magnetic
Resonance Imaging has gradually emerged as the preferred method of investigation in such a field
due to its superior capability of space and tissue density resolution. By designing dedicated laryngeal
radiofrequency coils and applying respiratory-triggered acquisition techniques that minimize
breathing and swallowing related artifacts, high-quality images (with an isotropic resolution of up
to 1mm) acquired in a few minutes will allow surgeons to obtain a set of nearly histopathologic
macro-sections of the entire larynx, with marvelous understanding of the 3D extent of the lesion to
be treated.
As already demonstrated by several reports, among which those first published by Blakeslee
in 1984 (3) and later reproduced by Peretti et al. (4, 5), Hamzany et al. showed that an accurate
pre- and intraoperative diagnostic work-up allows not only to avoid any preemptive biopsy, directly
treating a given glottic lesion by a single stage TLM session, but also that it is possible to minimize
the rates of over- and undertreatments in terms of depth of partial cordectomy to 10%. In particular,
the routine use of intraoperative visual aids such as Narrow Band Imaging, based on the biologic
endoscopy concept previously described by two of us (6), may greatly help in reducing the amount
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of surgical mistakes in terms of superficial positive margins, one
of the most potent prognosticators in every oncologic surgical
procedure, as herein demonstrated in a series of 634 patients by
Fiz et al.
Even though the vast majority of papers in the literature
details outcomes of primary TLM for management of naive
glottic tumors, Meulemans et al. confirm the applicability of such
a therapeutic weapon even in the (much more troublesome)
scenario of selected post-actinic persistent/recurrent tumors.
Even though oncologic outcomes remain satisfactory, not
surprisingly the Belgian Authors found a statistically significant
lower local recurrence-free survival and ultimate local control
rate in such a clinical setting. However, being able to ultimately
preserve the larynx in 65% of their patients, the Authors
definitively turned the old tenet upside down that the only
possible salvage option after radiation failure would be total
laryngectomy.
A comprehensive approach to the categorization of different
subgroups of glottic lesions to be treated by TLM is applied
by Piazza et al. rigorously assessing their dataset of 410 T1–
T3 untreated patients and trying to overcome the intrinsic
limitations of the contemporary edition of the TNM staging
system in giving an affordable prognostication. The resulting 3D
map of isoprognostic zones can effectively guide surgeons within
their multidisciplinary teams in discussing the pros and cons of
transoral management of a glottic tumor, balancing alternative
therapeutic options in the search for the best compromise
between oncologic cure and functional results.
Even though less frequently encountered and with different
loco-regional patterns of spreading, even supraglottic carcinomas
may be effectively managed by TLM as herein demonstrated by
two independent groups of Italian and German surgeons. In fact,
both Carta et al. and Ambrosch et al. report excellent oncologic
outcomes in treating T1–T3 (and selected T4 lesions in the
German series) with such an approach, claiming optimal vocal
and swallowing outcomes that are comparatively better than
those traditionally described after open-partial laryngectomies
or non-surgical treatments. Interestingly, the Italian group also
proposes a slight technical modification to the more advanced
type of endoscopic supraglottic resection according to the
ELS classification (7), by preserving the inferior third of the
arytenoid cartilage and thus greatly reducing the risk of long-
lasting post-operative aspiration described by others after such a
procedure (8). Tumors of the posterior laryngeal compartment,
i.e., involving the posterior third of the vocal cords, posterior
commissure, and medial aspect of the arytenoid cartilages,
have been traditionally regarded as biologically insidious and
technically demanding, especially in case of superficial lesions
not requiring open surgery, but still located in a difficult area
to be managed by the transoral route via a standard orotracheal
intubation. Mora et al. herein brilliantly introduce subglottic
high frequency jet ventilation through a 4mm laser-safe catheter
as a method that allows superb control of superficial resection
margins in such a rare tumor location.
One of the most limiting factors in teaching and learning
TLM techniques is the contemporary relative paucity of
anatomical descriptions and text books specifically focusing
on structural details from the inside out. This, indeed, is
definitively the most intriguing nuance represented by the
work of Perotti et al. depicting in great detail the vascular
anatomy of the supraglottic, glottic, and subglottic regions, with
special attention to practical tips that every transoral surgeon
should master in order to anticipate or treat bleeding in such
procedures.
Interestingly, about 25% of papers in the present Research
Topic have been devoted to discussion of transoral robotic
surgery (TORS) for laryngeal cancer. A comprehensive review
on the subject has been performed by Gorphe demonstrating
in a balanced way the present pros and cons of such a
surgical approach to the laryngeal oncologic issues. Even though
comparative analysis between the “classic” TLM technique and
TORS are still scant and frequently surpassed by quickly evolving
robotic technology, this new approach to minimally-invasive
surgery performed through natural orifices is clearly here to stay.
For example, some may argue that the reported tracheostomy
rate (32%) in the large series of supraglottic cancers managed
by TORS from Stubbs et al. and, especially, their relatively
long decannulation time (4 months) are less appealing than
those reported in the major TLM series, two of which are
also included in the present collection. However, as usual,
direct comparisons between different series, with a different
tumor mix treated in diverse health care systems, are difficult
and limited in their intrinsic value. Moreover, new robots
and improved anesthesiologic techniques may well change the
treatment profile of these patients in the near future. The growing
active interest in TORS is also evoked by Mäkitie et al. Their
short paper is a purely epidemiological view on TORS in the
Scandinavian countries, not addressing oncological outcomes,
need for additional non-surgical treatment, or complications.
The ambition of this paper is no more than an urgent invitation
to summarize the need for rigorous data collection within a
future clinical trial, as well as for prospectively formulating
high management standards to minimize future side effects
and undue sequelae. A complicating factor in interpreting the
findings is that most of the centers analyzed are obviously
in the beginning or the middle of their learning curve. The
Authors do not provide scientific data detailing the likely (causal)
relationship between the number of surgeries and outcomes,
nor on the expected positive effect of their proposed further
centralization (9). This criticism prompted some esteemed
Editorial Board members to recommend against publication,
while others heavily supported its inclusion in the present
Research Topic. The final decision, as you can see, was to
include such a paper as a photograph of a peculiar moment in
the development of TORS in a large portion of the European
Community.
In conclusion, we are strongly convinced that some of the
nuances presented in this Research Topic, and definitively
many others still to be developed or published, will greatly
contribute in reshaping the future indications, outcomes, and
limits of transoral treatments of laryngeal cancer. Collation
of such different hints, suggestions, and proposals starts
from the research benches, proceeds through publications and
conferences, and ends up in the operatory rooms and outpatient
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clinics of the real world to improve overall laryngeal cancer care.
We are deeply honored to be part of such a chain, and truly
hope this Research Topic will fuel further interests in readers and
scholars.
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